Implantable drug delivery devices Market - Global Industry Analysis

Market Overview     

The global Implantable drug delivery devices market accounted for USD 14.9 Billion in 2020 and is expected to reach USD 26.7 Billion by 2028, growing at a CAGR of around 7.5% between 2021 and 2028.      

With the help of implantable drug delivery devices, it has become possible to have site-specific drug delivery. This is of great importance in cardiology and oncology. Implantable drug delivery devices help in the constant release of a therapeutic agent. Implantable drug delivery devices require smaller dosages as compared its counterpart which in turn reduces the probability of side effects from drugs.  Implantable drug delivery devices are used in a number of applications including HIV/AIDS prevention, diabetes management, chronic pain management, central nervous system (CNS) health, oncology, contraception, and cardiology.

COVID-19 Impact Analysis  

The restrictions imposed by various nations to contain COVID had stopped the demand and supply resulting in a disruption across the whole supply chain. However, the global markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year.  The global Implantable drug delivery devices market has witnessed a slight decline in the sales for short term to the lockdown enforcement placed by governments in order to contain COVID spreading. The restrictions imposed by various nations to contain COVID had stopped the production resulting in a disruption across the whole supply chain.  However, the global markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year. The significant decrease in the global Implantable drug delivery devices market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.  

Growth Factors

Global implantable drug delivery devices market is primarily driven by growing aging population and prevalence of target diseases such as diabetic retinopathy and chronic diseases. Other major driving factors for growth of implantable drug delivery devices market is rising cases of unwanted pregnancies. However, strict government regulations implied on this industry and the high cost of these devices are major restraints that may curb the growth of the market.

Nonetheless, the introduction of new and more effective implantable drug delivery devices is likely to disclose the new avenues for implantable drug delivery devices market in the near future.

Report Scope:  

Segment Analysis Preview  

The implantable drug delivery devices market is segmented on the basis of different products including drug infusion pumps, drug delivery devices, bio-absorbable stents, coronary drug eluting stents, brachytherapy seeds, contraceptive drug delivery implants and others. In 2020, implantable drugs infusion pumps were the largest segment of implantable drug delivery devices market and accounted for largest share of the total market. Additionally, it is expected to continue its dominance and be the fastest growing segment in the global market over the forecast period.  Contraceptive drug delivery device is another major product segment of implantable drug delivery devices.

 Oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and others are the key end-user segment of the global implantable drug delivery devices market. The cardiovascular end-user segment dominated the market in terms of revenue. The cardiovascular segment is likely to have a significant growth within the forecast period and is projected to the fastest growing segment as a result of increasing usage of bio-absorbable stents.

Regional Analysis Preview  

North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global implantable drug delivery devices market. North America is expected to remain the dominant region over the forecast period. Europe was a second largest market for implantable drug delivery devices in 2020. Asia Pacific is expected to be the fastest growing region in implantable drug delivery devices market during the forecast period. Moreover, Latin America is also expected to show noticeable growth for this market in the years to come.

Key Market Players & Competitive Landscape

Some of the major players of the global implantable drug delivery devices market include Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others.

The global Implantable drug delivery devices Market is segmented as follows:

By Products

• Drug Infusion Pumps
• Drug Delivery Devices
• Bio-Absorbable Stents
• Coronary Drug Eluting Stents
• Brachytherapy Seeds
• Contraceptive Drug Delivery Implants
• Others

By End-users

• Oncology
• Contraception
• Cardiovascular
• Ophthalmology
• Inflammatory Conditions
• Diabetes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

• Chapter No. 1 Introduction
  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope
• Chapter No. 2 Executive Summary
  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By Product
      • 2.1.1.2. Market Attractiveness Analysis, By End-user
      • 2.1.1.3. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Implantable drug delivery devices Market, 2016 – 2028 (USD Billion)
  • 2.4. Insights from Primary Respondents
• Chapter No. 3 COVID 19 Impact Analysis
  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics
• Chapter No. 4 Implantable drug delivery devices Market – Product Segment Analysis
  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
  • 4.2. Drug Infusion Pumps
    • 4.2.1. Market Size and Forecast, By Region (USD Billion)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.3. Drug Delivery Devices
    • 4.3.1. Market Size and Forecast, By Region (USD Billion)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.4. Bio-Absorbable Stents
    • 4.4.1. Market Size and Forecast, By Region (USD Billion)
    • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.5. Coronary Drug Eluting Stents
    • 4.5.1. Market Size and Forecast, By Region (USD Billion)
    • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.6. Brachytherapy Seeds
    • 4.6.1. Market Size and Forecast, By Region (USD Billion)
    • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.7. Contraceptive Drug Delivery Implants
    • 4.7.1. Market Size and Forecast, By Region (USD Billion)
    • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.8. Others
    • 4.8.1. Market Size and Forecast, By Region (USD Billion)
    • 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.8.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 5 Implantable drug delivery devices Market – End-user Segment Analysis
  • 5.1. Overview
    • 5.1.1. Market Revenue Share, By End-user, 2020 & 2028
  • 5.2. Onculogy
    • 5.2.1. Market Size and Forecast, By Region (USD Billion)
    • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.3. Contraception
    • 5.3.1. Market Size and Forecast, By Region (USD Billion)
    • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.4. Cardiovascular
    • 5.4.1. Market Size and Forecast, By Region (USD Billion)
    • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.5. Ophthalmulogy
    • 5.5.1. Market Size and Forecast, By Region (USD Billion)
    • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.6. Inflammatory Conditions
    • 5.6.1. Market Size and Forecast, By Region (USD Billion)
    • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.7. Contraceptive Drug Delivery Implants
    • 5.7.1. Market Size and Forecast, By Region (USD Billion)
    • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.7. Others
    • 5.7.1. Market Size and Forecast, By Region (USD Billion)
    • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.1. Overview
    • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
  • 6.2. North America
    • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 6.2.2. North America Market Revenue, By Product, 2016 – 2028
    • 6.2.3. North America Market Revenue, By End-user, 2016 – 2028
    • 6.2.5. U.S.
      • 6.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
      • 6.2.5.2. U.S. Market Revenue, By End-user, 2016 – 2028
    • 6.2.6. Canada
      • 6.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
      • 6.2.6.2. Canada Market Revenue, By End-user, 2016 – 2028
    • 6.2.7. Mexico
      • 6.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
      • 6.2.7.2. Mexico Market Revenue, By End-user, 2016 – 2028
  • 6.3. Europe
    • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 6.3.2. Europe Market Revenue, By Product, 2016 – 2028
    • 6.3.3. Europe Market Revenue, By End-user, 2016 – 2028
    • 6.3.5. Germany
      • 6.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
      • 6.3.5.2. Germany Market Revenue, By End-user, 2016 – 2028
    • 6.3.6. France
      • 6.3.6.1. France Market Revenue, By Product, 2016 – 2028
      • 6.3.6.2. France Market Revenue, By End-user, 2016 – 2028
    • 6.3.7. U.K.
      • 6.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
      • 6.3.7.2. U.K. Market Revenue, By End-user, 2016 – 2028
    • 6.3.8. Italy
      • 6.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
      • 6.3.8.2. Italy Market Revenue, By End-user, 2016 – 2028
    • 6.3.9. Spain
      • 6.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
      • 6.3.9.2. Spain Market Revenue, By End-user, 2016 – 2028
    • 6.3.10. Rest of Europe
      • 6.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
      • 6.3.10.2. Rest of Europe Market Revenue, By End-user, 2016 – 2028
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 6.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
    • 6.4.3. Asia Pacific Market Revenue, By End-user, 2016 – 2028
    • 6.4.5. China
      • 6.4.5.1. China Market Revenue, By Product, 2016 – 2028
      • 6.4.5.2. China Market Revenue, By End-user, 2016 – 2028
    • 6.4.6. Japan
      • 6.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
      • 6.4.6.2. Japan Market Revenue, By End-user, 2016 – 2028
    • 6.4.7. India
      • 6.4.7.1. India Market Revenue, By Product, 2016 – 2028
      • 6.4.7.2. India Market Revenue, By End-user, 2016 – 2028
    • 6.4.8. South Korea
      • 6.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
      • 6.4.8.2. South Korea Market Revenue, By End-user, 2016 – 2028
    • 6.4.9. South-East Asia
      • 6.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
      • 6.4.9.2. South-East Asia Market Revenue, By End-user, 2016 – 2028
    • 6.4.10. Rest of Asia Pacific
      • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 6.4.10.2. Rest of Asia Pacific Market Revenue, By End-user, 2016 – 2028
  • 6.5. Latin America
    • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 6.5.2. Latin America Market Revenue, By Product, 2016 – 2028
    • 6.5.3. Latin America Market Revenue, By End-user, 2016 – 2028
    • 6.5.5. Brazil
      • 6.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
      • 6.5.5.2. Brazil Market Revenue, By End-user, 2016 – 2028
    • 6.5.6. Argentina
      • 6.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
      • 6.5.6.2. Argentina Market Revenue, By End-user, 2016 – 2028
    • 6.5.7. Rest of Latin America
      • 6.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
      • 6.5.7.2. Rest of Latin America Market Revenue, By End-user, 2016 – 2028
  • 6.6. The Middle-East and Africa
    • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 6.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
    • 6.6.3. The Middle-East and Africa Market Revenue, By End-user, 2016 – 2028
    • 6.6.5. GCC Countries
      • 6.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
      • 6.6.5.2. GCC Countries Market Revenue, By End-user, 2016 – 2028
    • 6.6.6. South Africa
      • 6.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.6.2. South Africa Market Revenue, By End-user, 2016 – 2028
    • 6.6.7. Rest of Middle-East Africa
      • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By End-user, 2016 – 2028
• Chapter No. 7: Implantable drug delivery devices Market – Industry Analysis
  • 7.1. Introduction
  • 7.2. Market Drivers
    • 7.2.1. Driving Factor 1 Analysis
    • 7.2.2. Driving Factor 2 Analysis
  • 7.3. Market Restraints
    • 7.3.1. Restraining Factor Analysis
  • 7.4. Market Opportunities
    • 7.4.1. Market Opportunity Analysis
  • 7.5. Porter’s Five Forces Analysis
  • 7.6. PEST Analysis
  • 7.7. Regulatory Landscape
  • 7.8. Technology Landscape
  • 7.9. Regional Market Trends
    • 7.9.1. North America
    • 7.9.2. Europe
    • 7.9.3. Asia Pacific
    • 7.9.4. Latin America
    • 7.9.5. The Middle-East and Africa
  • 7.10. Pricing Analysis
  • 7.11. Value Chain Analysis
  • 7.12. Downstream Buyers
  • 7.13. Distributors/Traders List
• Chapter No. 8: Competitive Landscape
  • 8.1. Company Market Share Analysis – 2019
    • 8.1.1. Global Implantable drug delivery devices Market: Company Market Share, 2019
    • 8.1.2. Global Implantable drug delivery devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
    • 8.1.3. Global Implantable drug delivery devices Market, Company Y-o-Y Growth, 2017 – 2019 (%)
    • 8.1.4. Global Implantable drug delivery devices Market: Radar Determinant Chart, 2019
  • 8.2. Strategic Developments
    • 8.2.1. Acquisitions & Mergers
    • 8.2.2. New Product Launch
    • 8.2.3. Regional Expansion
  • 8.3. Company Strategic Developments – Heat Map Analysis
• Chapter No. 9: Company Profiles
  • 9.1. Bausch & Lomb Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Product Portfolio
    • 9.1.4. Financial Overview
    • 9.1.5. Operating Business Segments
    • 9.1.6. Business Performance
    • 9.1.7. Recent Developments
  • 9.2. Dickinson and Company
  • 9.3. Medtronic Inc.
  • 9.4. Boston Scientific Corporation
  • 9.5. Arrow International
  • 9.6. Theragenics
  • 9.7. Varian Medical Systems
  • 9.8. Allergan Inc.
  • 9.9. Merck
  • 9.10. Bayer Healthcare
  • 9.11 Abbott laboratories
• Chapter No. 10: Marketing Strategy Analysis
  • 10.1. Marketing Channel
  • 10.2. Direct Marketing
  • 10.3. Indirect Marketing
  • 10.4. Marketing Channel Development Trends
  • 10.5. Economic/Pulitical Environmental Change
• Chapter No. 11: Research Methodology
  • 11.1. Research Methodology
  • 11.2. Phase I - Secondary Research
  • 11.3. Phase II - Data Modeling
    • 11.3.1. Company Share Analysis Model
    • 11.3.2. Revenue Based Modeling
  • 11.4. Phase III - Primary Research
  • 11.5. Research Limitations
    • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By End-user
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Implantable drug delivery devices Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028 
FIG NO. 7. Global Implantable drug delivery devices Market for Drug Infusion Pumps, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Implantable drug delivery devices Market for Drug Infusion Pumps, By Country, 2020 & 2028
FIG NO. 9. Global Implantable drug delivery devices Market for Drug Delivery Devices, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Implantable drug delivery devices Market for Drug Delivery Devices, By Country, 2020 & 2028
FIG NO. 11. Global Implantable drug delivery devices Market for Bio-Absorbable Stents, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Implantable drug delivery devices Market for Bio-Absorbable Stents, By Country, 2020 & 2028
FIG NO. 13. Global Implantable drug delivery devices Market for Coronary Drug Eluting Stents, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Implantable drug delivery devices Market for Coronary Drug Eluting Stents, By Country, 2020 & 2028
FIG NO. 15. Global Implantable drug delivery devices Market for Brachytherapy Seeds, Revenue (USD Billion) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Implantable drug delivery devices Market for Brachytherapy Seeds, By Country, 2020 & 2028
FIG NO. 17. Global Implantable drug delivery devices Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Implantable drug delivery devices Market for Others, By Country, 2020 & 2028
FIG NO. 19. Global Implantable drug delivery devices Market for Contraceptive Drug Delivery Implants, Revenue (USD Billion) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Implantable drug delivery devices Market for Contraceptive Drug Delivery Implants, By Country, 2020 & 2028
FIG NO. 21. Market Revenue Share, By End-user, 2020 & 2028
FIG NO. 22. Global Implantable drug delivery devices Market for Oncology, Revenue (USD Billion) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Implantable drug delivery devices Market for Oncology, By Country, 2020 & 2028 
FIG NO. 24. Global Implantable drug delivery devices Market for Contraception, Revenue (USD Billion) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Implantable drug delivery devices Market for Contraception, By Country, 2020 & 2028
FIG NO. 26. Global Implantable drug delivery devices Market for Cardiovascular, Revenue (USD Billion) 2016 – 2028 
FIG NO. 27. Comparative Revenue Analysis of Implantable drug delivery devices Market for Cardiovascular, By Country, 2020 & 2028
FIG NO. 28. Global Implantable drug delivery devices Market for Ophthalmology, Revenue (USD Billion) 2016 – 2028
FIG NO. 29. Comparative Revenue Analysis of Implantable drug delivery devices Market for Ophthalmology, By Country, 2020 & 2028
FIG NO. 30. Global Implantable drug delivery devices Market for Inflammatory Conditions, Revenue (USD Billion) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Implantable drug delivery devices Market for Inflammatory Conditions, By Country, 2020 & 2028
FIG NO. 32. Global Implantable drug delivery devices Market for Diabetes, Revenue (USD Billion) 2016 – 2028
FIG NO. 33. Comparative Revenue Analysis of Implantable drug delivery devices Market for Diabetes, By Country, 2020 & 2028
FIG NO. 34. Global Implantable drug delivery devices Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Implantable drug delivery devices Market for Others, By Country, 2020 & 2028
FIG NO. 36. Global Implantable drug delivery devices Market Revenue Share, By Region, 2020 & 2028
FIG NO. 37. North America Implantable drug delivery devices Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 38. Porter’s Five Forces Analysis for Global Implantable drug delivery devices Market
FIG NO. 39. PEST Analysis for Global Implantable drug delivery devices Market
FIG NO. 40. Pricing Analysis for Global Implantable drug delivery devices Market
FIG NO. 41. Value Chain Analysis for Global Implantable drug delivery devices Market
FIG NO. 42. Company Share Analysis, 2019
FIG NO. 43. Radar Determinant Chart, 2019
FIG NO. 44. Company Strategic Developments – Heat Map Analysis
FIG NO. 45. Bausch & Lomb Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 46. Bausch & Lomb Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 47. Market Channels
FIG NO. 48. Marketing Channel Development Trend
FIG NO. 49. Growth in World Gross Product, 2008-2018
FIG NO. 50. Research Methodology – Detailed View
FIG NO. 51. Research Methodology
 

Table Of Tables

List of Tables 

TABLE NO. 1. Global Implantable drug delivery devices Market: Snapshot
TABLE NO. 2. Quarterly Implantable drug delivery devices Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Implantable drug delivery devices Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Implantable drug delivery devices Market for Drug Infusion Pumps, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Implantable drug delivery devices Market for Drug Delivery Devices, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Implantable drug delivery devices Market for Bio-Absorbable Stents, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Implantable drug delivery devices Market for Coronary Drug Eluting Stents, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Implantable drug delivery devices Market for Brachytherapy Seeds, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11: Global Implantable drug delivery devices Market for Contraceptive Drug Delivery Implants, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12: Global Implantable drug delivery devices Market for others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Implantable drug delivery devices Market for Oncology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14 Global Implantable drug delivery devices Market for Contraception, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Implantable drug delivery devices Market for Cardiovascular, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. Global Implantable drug delivery devices Market for Ophthalmology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 17. Global Implantable drug delivery devices Market for Inflammatory Conditions, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 18. Global Implantable drug delivery devices Market for Diabetes, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 19. Global Implantable drug delivery devices Market for Others, by Region, 2016 – 2028 (USD Billion) 
TABLE NO. 20. Global Implantable drug delivery devices Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 21. North America Implantable drug delivery devices Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 22. North America Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 23. North America Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 24. U.S. Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 25. U.S. Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 26. Canada Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 27. Canada Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 28. Mexico Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 29. Mexico Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 30. Drivers for the Implantable drug delivery devices Market: Impact Analysis
TABLE NO. 31. Restraints for the Implantable drug delivery devices Market: Impact Analysis
TABLE NO. 32. Major Buyers of Implantable drug delivery devices  
TABLE NO. 33. Distributors/Traders List of Implantable drug delivery devices
TABLE NO. 34. Global Implantable drug delivery devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 35: Global Implantable drug delivery devices Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)